Acknowledgements
The authors acknowledge Kushali Patel, PharmD, an employee of Bayer, for medical writing support for the development of this infographic, in accordance with Good Publication Practice guidelines (https://www.acpjournals.org/doi/10.7326/M22-1460).
Funding
The QUASAR study (NCT05850520) was sponsored by Bayer Consumer Care AG, Basel, Switzerland.
Author information
Authors and Affiliations
Contributions
All authors equally contributed to the concept and creation of the visual abstract.
Corresponding author
Ethics declarations
Competing interests
AC has received consultancy fees from Alcon, Apellis, Astellis, Bayer, Novartis, Roche, Opthea, and Zeiss, and grant funding from Bayer, Novartis and Roche. SL is an employee, investor, and patent holder of Bayer Consumer Care AG. LB is an employee of Bayer Consumer Care AG. AJB is an employee of Regeneron Pharmaceuticals, Inc. FS is an employee of Regeneron Pharmaceuticals, Inc.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chang, A., Leal, S., Brunck, L. et al. Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusion. Eye (2026). https://doi.org/10.1038/s41433-026-04246-1
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41433-026-04246-1
